Aegle Health Partners is transforming healthcare financing by providing innovative solutions that enhance traditional stop-loss insurance with cost-effective alternatives. Their offerings, such as Aegle Accel and Risk Financing, help self-insured employers and risk-bearing entities manage healthcare funding risks more effectively. With a focus on flexibility and affordability, Aegle's solutions aim to mitigate financial challenges and improve cash flow predictability for organizations looking to self-insure their healthcare coverage. The company is positioned to redefine healthcare risk financing, leveraging a team of experts from various sectors to drive innovation and growth in the market.

Biotia is a health-tech company based in New York that utilizes sequencing-based technology and proprietary AI to accurately identify microorganisms and antimicrobial resistance. Their mission is to combat infectious diseases by deploying a leading reference library of microbes globally. As a spinout from the Jacobs Technion-Cornell Institute, Biotia operates a CLIA-certified lab and has received regulatory approval for its innovative diagnostic assays, including the BIOTIA-ID Urine test. The company is positioned at the forefront of genomic-based diagnostics, leveraging advanced technology to improve patient outcomes and public health responses to infectious disease threats.

Debut is an unconventional innovation company that integrates breakthrough biotechnology and brand creation to build businesses that represent the next generation of sustainable wellness. They harness nature, science, and creativity to create high-performing, sustainable cosmetic bioactive ingredients through advanced biomanufacturing approaches. With a proprietary Bio2Consumer™ platform and an extensive IP portfolio of over 7,000 active ingredients, Debut partners with major beauty brands to enhance product performance and sustainability. Their fully vertical integration capabilities allow them to deliver innovative solutions at unprecedented speed, positioning them as a leader in the beauty industry.

Ellipsis Health is a pioneering company focused on automating care management through its patented voice biomarker technology. By leveraging peer-reviewed science, the company enables healthcare partners to enhance patient and provider experiences, streamline workflows, and significantly reduce care costs. With over 2 million labeled minutes of speech analyzed, Ellipsis Health is positioned to transform mental health care by prioritizing it alongside physical health, thus creating a comprehensive approach to whole person care. Their innovative solutions have led to a 50% reduction in administrative tasks, showcasing their traction and effectiveness in the healthcare market.

Great Expectations is a data quality platform that provides an end-to-end solution for data quality processes through its products, GX Cloud and GX Core. Founded in 2017, the company has rapidly gained traction in the data community, offering a unique Expectation-based approach to testing that is accessible to both technical and non-technical stakeholders. With a focus on collaboration and visibility, Great Expectations enables organizations to trust their data and improve their data quality processes. The company has successfully raised venture capital and is positioned as a leader in the data quality movement, with a growing user base and a commitment to open-source principles.

Helm takes the confusion out of health insurance by making every service easily shoppable, upfront. Guaranteed.

Ignite Data is transforming clinical trials through its cloud-based Virtual Research Assistant, Archer. This system-agnostic solution facilitates seamless interoperability between electronic health records (EHR) and electronic data capture (EDC) systems, ensuring secure and efficient transfer of clinical data. By automating regulatory-grade data collection, Archer significantly reduces the time and errors associated with manual data transcription, enhancing productivity and accelerating patient access to treatments. With a strong focus on data security and compliance, Ignite Data positions itself as a leader in the clinical trial integration market, backed by substantial funding and partnerships with major healthcare organizations.

Inito is a medical technology company that offers an all-in-one fertility monitor, enabling couples to track their fertility hormones at home. The device measures four key hormones—Estrogen, LH, Pd G, and FSH—providing personalized insights into ovulation cycles. This differentiation from traditional ovulation tests, which typically only measure LH, positions Inito uniquely in the fertility market. With over 20,000 couples using the product, Inito has established a strong market presence and traction, making it a compelling option for those seeking to conceive more effectively.

Intellihealth, now rebranded as Flyte Health, focuses on obesity care that transcends traditional weight loss methods. The company leverages decades of research and clinical expertise to provide a comprehensive treatment model that combines medical care, coaching, and pharmacotherapy. Their innovative approach utilizes new medications and generics to enhance patient outcomes, making them a leader in the obesity medicine field. With a strong emphasis on personalized care, Flyte Health aims to improve the health of individuals and organizations alike, demonstrating significant returns on investment for employers through lower healthcare costs and improved employee well-being.

Leash Biosciences is transforming drug design through machine learning by building a proprietary dataset of protein-molecule interactions. They have measured 17.4 billion interactions and designed 6.7 million molecules, focusing on closing the data gap in drug discovery. Their innovative software rapidly designs new molecules, making them more likely to succeed in drug development. With plans to measure 500 protein targets against 20 million molecules, they are positioned to develop new medicines, particularly in oncology, while collaborating with biopharma partners to explore new opportunities.

Marigold Health is an anonymous social network designed to support individuals with mental health and substance use conditions through peer support. The platform offers 24/7 access to wellness tools, goal planning, and theme-based chat groups, fostering a community where members can share experiences and find inspiration. With a tech-enabled and human-centered approach, Marigold integrates with existing care teams, providing personalized support while enhancing treatment outcomes. The service utilizes Natural Language Processing (NLP) to address the highest needs of users, making it a valuable resource for recovery.

Nest Health is a whole-family healthcare practice that provides convenient and compassionate care to families at home and online. The company offers a range of services including 24/7 access, home and virtual visits, and comprehensive care for all family members, ensuring that healthcare is easy and accessible. By integrating healthcare into the home environment, Nest Health differentiates itself from traditional healthcare models, eliminating the need for multiple appointments and reducing the stress associated with healthcare visits. Their services are available at no additional cost to families covered by participating health plans, positioning them as a valuable resource in the healthcare market.